Phase 4 Study in the Elderly Patients With T2DM
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Phase 4 Study in the Elderly Patients With T2DM is a clinical trial[1].
Key Facts
- Phase 4 Study in the Elderly Patients With T2DM is in the country of France[2].
- Phase 4 Study in the Elderly Patients With T2DM's instance of is recorded as clinical trial[3].
- Phase 4 Study in the Elderly Patients With T2DM's start time is recorded as +2010-10-31T00:00:00Z[4].
- Phase 4 Study in the Elderly Patients With T2DM's end time is recorded as +2011-12-31T00:00:00Z[5].
- Phase 4 Study in the Elderly Patients With T2DM's sponsor is recorded as Novartis[6].
- Phase 4 Study in the Elderly Patients With T2DM's main subject is recorded as diabetes[7].
- Phase 4 Study in the Elderly Patients With T2DM's number of participants is recorded as {'unit': '1', 'amount': '+46'}[8].
- Phase 4 Study in the Elderly Patients With T2DM's title is recorded as A Multicenter, Prospective, Randomized, Open-label, Parallel Group Study to Investigate the Clinical Benefit on Hypoglycemia Frequency of 24 Weeks Treatment With Galvus Versus Usual Care (Any OAD of Another Class Added to Metformin Within SmPc) in Older Patients With Type 2 Diabetes Insufficiently Controlled by Metformin Monotherapy.[9].
- Phase 4 Study in the Elderly Patients With T2DM's short name is recorded as GLYCEMIA[10].
- Phase 4 Study in the Elderly Patients With T2DM's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[11].
- Phase 4 Study in the Elderly Patients With T2DM's ClinicalTrials.gov ID is recorded as NCT01238978[12].
- Phase 4 Study in the Elderly Patients With T2DM's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[13].
- Phase 4 Study in the Elderly Patients With T2DM's research intervention is recorded as vildagliptin[14].
- Phase 4 Study in the Elderly Patients With T2DM's clinical trial phase is recorded as phase IV clinical trial[15].
- Phase 4 Study in the Elderly Patients With T2DM's research site is recorded as Novartis[16].
- Phase 4 Study in the Elderly Patients With T2DM's study type is recorded as interventional study[17].